Shopping Cart (Login required)

Press Releases

Language

Year

Thu, 30 Apr 2020 10:30:00 +0200

Biotage’s Chairman of the Board has sold part of his shares in Biotage – remains as a long-term owner

Tue, 28 Apr 2020 13:00:00 +0200

Biotage AB (publ) Interim report January - March 2020

Tue, 28 Apr 2020 13:00:00 +0200

NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ)

The shareholders in Biotage AB (publ), Reg. No. 556539-3138, with its registered office in Uppsala kommun, Uppsala län, are hereby summoned to the Annual General Meeting, to be held on Thursday, June 4, 2020, at 4.00 p.m., at Biotage AB’s head office, Vimpelgatan 5 in Uppsala, Sweden.
Tue, 28 Apr 2020 13:00:00 +0200

Biotage AB (publ) publishes its 2019 Annual Report and Corporate Governance Report

Fri, 17 Apr 2020 07:00:00 +0200

Biotage Board withdraw the dividend proposal

Following further analysis and considerations, the Board has decided to withdraw the dividend proposal of SEK 1.60 per share and instead propose that no dividend be paid in connection with the annual general meeting.
Thu, 26 Mar 2020 16:00:00 +0100

Biotage postpones the AGM until June 4, 2020

Tue, 17 Mar 2020 13:30:00 +0100

Biotage AB (publ) appoints new CFO

Mon, 02 Mar 2020 08:00:00 +0100

Biotage appoints Lars Bäckman as Interim CFO

Fri, 07 Feb 2020 07:30:00 +0100

Year-end report January - December 2019

Investments in growth brings Biotage’s annual sales past the billion SEK milestone
Thu, 07 Nov 2019 16:30:00 +0100

Resolutions at the Extra General Meeting in Biotage AB on November 7, 2019

Tue, 05 Nov 2019 07:30:00 +0100

Interim report January - September 2019

A quarter of records
Mon, 14 Oct 2019 06:30:00 +0200

NOTICE OF EXTRAORDINARY GENERAL MEETING IN BIOTAGE AB (PUBL)

Tue, 01 Oct 2019 05:30:00 +0200

Erika Söderberg Johnson leaves Biotage

Tue, 16 Jul 2019 06:30:00 +0200

Interim report January - June 2019

Fri, 24 May 2019 16:00:00 +0200

Tomas Blomquist – new CEO & President of Biotage

Contact persons: Torben Jörgensen, CEO Tel: +46 707 49 05 84, torben.jorgensen@biotage.com Thomas Eklund, Chairman of the Board Tel: +46 (0)708 24 20 25, thomas.eklund@investorab.com
Wed, 24 Apr 2019 16:00:00 +0200

Resolutions at the Annual General Meeting in Biotage AB on April 24, 2019

Wed, 24 Apr 2019 13:00:00 +0200

Interim report  January – March 2019

Wed, 17 Apr 2019 08:00:00 +0200

Biotage AB – changes in Nomination Committee proposal

Mon, 01 Apr 2019 08:00:00 +0200

Biotage AB (publ) publishes its 2018 Annual Report and Corporate Governance Report

Mon, 25 Mar 2019 07:30:00 +0100

NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ)

Mon, 25 Mar 2019 07:30:00 +0100

Biotage AB –Nomination Committee proposal for the election of Board of Directors and Chairman of the Board

Thu, 07 Feb 2019 07:30:00 +0100

Year-end report  January - December 2018

Thu, 31 Jan 2019 07:30:00 +0100

Biotage AB – changes in number of shares and votes

Tue, 15 Jan 2019 17:15:00 +0100

Biotage completes the acquisition of PhyNexus, Inc. and resolves on a share issue as part of the acquisition

Wed, 02 Jan 2019 07:45:00 +0100

The Nomination Committee of Biotage AB proposes a new director

Wed, 02 Jan 2019 07:45:00 +0100

The Board of Biotage AB initiates recruitment of a new CEO